MYC and ovarian carcinoma: The miR-145 and miR-23b are two oncosuppressor miRs that are known to be downregulated in ovarian cancer tissues [35] and in-silico analysis revealed that c-MYC and VEGF could be targets for these miRs (Table 1), which in turn are modulated by NGF/TRKA [35].